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1. Introduction 
Arthroscopy is performed with increasing frequency on a number of joints. In the lower 
limb the role of knee arthroscopy is well established with procedures enabling more 
accurate diagnosis and treatment of a myriad of conditions including but not being limited 
to meniscal injury and articular surface defects. Hip and ankle arthroscopy are less widely 
performed. However, despite this their use can be expected to increase as indications are 
better developed and techniques honed. 
While surgical technique often determines outcome in the long-term, analgesic control can 
significantly affect the patient’s satisfaction following a procedure as well as the overall 
acceptability of a procedure. Arthroscopic procedures in particular have enabled many 
procedures to be performed on a day case basis where as more traditional surgical 
interventions may have required at least an overnight hospital stay. This trend toward day 
case surgery also emphasizes the importance of optimum analgesic control. 
Traditionally intra-articular analgesic agents have been used following arthroscopic 
procedures as an augment to post-operative pain control. Classically these include the 
typical local anesthetic agents but also alternatives such as morphine. Recently however, the 
potential for deleterious effects of the intra-articular analgesics on the articular cartilage has 
been reported in a number of experimental studies, which has caused concern among 
practicing arthroscopic surgeons. The purpose of this chapter is to review the potential 
intra-articular analgesic agents used for pain control following lower limb arthroscopy and 
to also provide an up-to-date review of the evidence for the potential chondrotoxic effect of 
these agents. 
2. Analgesic agents 
Classical local anesthetic agents can be classified into the esters and amides. Amides 
including lignocaine and bupivacaine among others have commonly been used in 
arthroscopy. Local anesthetics block action potential initiation and propagation along 
sensory pathways by blocking the sodium channel transmembrane pores. Their activity is 
increased in alkaline conditions and this enables them to penetrate the nerve sheath and 
axonal membrane. 
Other agents to have been trialed as intra-articular agents include opiates or opiate related 
substances (e.g. morphine, tramadol), non-steroidal anti-inflammatory medications, 
benzodiazepines and NMDA-receptor antagonists (e.g. magnesium sulfate) among others. 
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2.1 Hip and ankle arthroscopy 
Numerous studies have assessed the ability of local anesthetic agents to provide pain 
control following arthroscopic procedures in the lower limb. A vast majority of these have 
focused on the knee and only a few have reported the use of local anaesthetic following hip 
and ankle arthroscopy(Middleton et al., 2006, Baker et al., 2011c).  
Of these two studies both found that intra-articular local anaesthetic was superior to either 
placebo or local anesthetic infiltrated around the arthroscopic portals (Table 1). The paucity 
of data here reflects the relative infancy of hip and ankle arthroscopy compared to knee 
arthroscopy and highlights the need for further work – hip arthroscopy in particular 
requires significant force to overcome the intra-articular negative pressures and can result in 
significant post-operative pain(Baker et al., 2011a). 
 
Author Setting Number Key findings 
(Baker et al., 
2011c) 
RCT 73 
Intra-articular bupivacaine superior to peri-portal bupivacaine at 
controlling pain following HIP arthroscopy 
(Middleton 
et al., 2006) 
RCT 35 
Intra-articular bupivacaine was superior to saline placebo in 
reducing post-operative VAS pain scores and need for 
supplemental analgesia following ANKLE arthroscopy 
Table 1. Studies assessing the benefit of intra-articular analgesic agents following hip and 
ankle arthroscopy 
2.2 Knee arthroscopy 
Numerous studies have attempted to establish the ideal intra-articular analgesic for pain 
control following knee arthroscopy (for a summary of these studies see Table2). The studies 
selected for inclusion here predominantly include those that use an intra-articular analgesic 
following surgery in a bolus dose fashion. Some studies that use it prior to surgery are also 
included for comparison sake particularly where comparison is later made with a bolus 
given following surgery. This section focuses on intra-articular analgesia given as an 
augment following surgery performed under general anesthesia or spinal anesthesia.   
Although many studies have found that classical local anesthetic agents are of benefit 
following knee arthroscopy a randomized controlled trial reported by Townsend et al noted 
that intra-articular bupivacaine was no more effective that bupivacaine infiltrated around 
the portal sites(Townshend et al., 2009). This equivalence takes on even more importance 
with the reported potential for the toxic effect on articular cartilage of bupivacaine and other 
similar agents.  
In general local anesthetics have been shown to be effective compared to placebo although 
this is not necessarily the case if the surgery is performed under spinal anesthetic when it 
appears the additional use of an intra-articular agent is negated by the spinal 
block(Santanen et al., 2001).  
Non-steroidal anti-inflammatory medications have been trialed as intra-articular agents but 
are not in wide spread use. A single study has found that tenoxicam was superior to 
bupivacaine following surgery but this was only with regards analgesic consumption – the 
reported pain scores were still similar(Cook et al., 1997). It was similarly found that 
lornoxicam resulted in lower pain scores than did bupivacaine in a randomized controlled 
trial of 40 patients(Fagan et al., 2003). The use of an anti-inflammatory into the joint cavity 
may play a role in pain control particularly when a significant inflammatory component to 
the intra-articular pathology is found(Izdes et al., 2003). 
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When compared to opiate type analgesics ropivacaine was shown in one study to provide 
quicker onset of analgesia but was not significantly better at 24 hours after 
surgery(Franceschi et al., 2001). The benefit of morphine as an intra-articular analgesic is 
questionable however as noted later and this perhaps reflects poorly on ropivacaine.  
Combinations of amide local anesthetics with other agents have been tried and this may 
represent the optimum way to control pain although at this point in time it is unknown. A 
combination of magnesium sulfate and bupivacaine was shown to be superior to either 
agent in isolation, which were again superior to placebo with regard pain scores following 
knee arthroscopy(Elsharnouby et al., 2008). These findings are supported by another study 
that also included morphine in the intra-articular cocktail but again found that a 
combination of agents was superior to any of the agents given in isolation(Farouk and Aly, 
2009). A combination of bupivacaine with fentanyl was shown to be superior to bupivacaine 
in isolation following knee arthroscopy in a randomized trial including 33 patients(Jawish et 
al., 1996). Despite these promising reports in combinations of an amide local anesthetic and 
an opiate type agent others have failed to find this multimodal approach any better than 
placebo alone(Aasbo et al., 1996). While pain intensity or pain scale score is a frequent 
measure in these studies, the actual need for additional analgesia is a limiting factor with 
regard the ability to perform a procedure as a day case or not and may reflect a more 
practical end-point for further research. 
Despite a small number of studies suggesting that morphine provides adequate analgesic 
control following knee a recent review of these studies has suggested that of the higher 
quality studies, most had a negative finding not in favor of its use as an intra-articular 
analgesic agent(Rosseland, 2005, Drosos et al., 2002). The key point of this review was that 
post-operative pain intensity was no less in the morphine treated groups than the placebo 
treated groups in the well-designed studies. This review is supported by a study by the 
same author group that found only those with intense pain after arthroscopy had any 
benefit from intra-articular morphine(Rosseland et al., 1999).  
Other agents have been studied in with some success including midazolam (increased the 
time to first analgesia after surgery compared to placebo), clonidine (additive effect with 
bupivacaine compared to bupivacaine alone) and neostigmine (more effective when 
compared to morphine)(Batra et al., 2008, Tamosiunas et al., 2005, Yang et al., 1998). 
Unfortunately these agents have been studies in a very limited capacity and a clear 
conclusion in unable to be drawn as their effectiveness.  
 
Author Setting Number Key findings 
(Aasbo et al., 
1996) 
RCT 107 
Patients randomised to receive either: bupivacaine (20ml of 
2.5mg/ml) + morphine (3mg); bupivacaine (20ml of 2.5mg/ml)  
alone; morphine (3mg) alone; or isotonic saline – no differences 
between the groups with regard analgesic requirement post-surgery 
(Al-Metwalli 
et al., 2008) 
RCT 60 
Intra-articular dexmedetomidine (-2-adrenergic agonist) given 
via the intra-articular route resulted in less post-operative pain 
and analgesic requirement than  either dexmedetomidine given 
intravenously or intra-articulat and intravenous placebo (saline) 
(Alagol et al., 
2004) 
RCT 210 
Intra-articular tramadol at doses 50-100mg provided good post-
operative analgesia with the higher doe more effectuve. The intra-
articular route was more effective than the intravenous route. 
(Batra et al., 
2008) 
RCT 60 
Intra-articular midazolam (50 or 75g/kg) provided superior, albeit 
briefly, analgesic control compared to saline placebo. Time to first 
analgesic requirement was 4.7 and 4.6 hours compared to 0.7. 
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Author Setting Number Key findings 
(Buerkle et 
al., 2000) 
RCT 60 
Patients given morphine (1mg) and clonidine (150g)  intra-
articularly in combination had lower VAS pain scores at 2 hours 
post-surgery and lower need for rescue analgesia compared to 
groups given either agent in isolation or saline placebo 
(Calmet et 
al., 2004) 
RCT 80 
Following arthroscopic meniscectomy, patients receiving intra-
articular ketorolac (60mg) had better post-operative pain control and 
less need for rescue analgesia compared to those receiving 10ml of 
0.25% bupivacaine, 1mg of morphine or normal saline placebo. 
(Cepeda et 
al., 1997) 
RCT 112 
Intra-articular and subcuticular morphine (10mg) and 
intraarticuular bupivacaine (20ml 0.5%) were compared with 
noraml saline placebo. Single dose morphine by either route 
provided superior pain conrol with lower pain scores at 6- and 3-
hours post-surgery. 
(Colbert et 
al., 1999) 
RCT 88 
Patients receiving intra-articular tenoxicam had lower pain scores at 
30-180 minutes post-surgery and required less analgesia later than 
thos receiving the same drug intravenously. 
(Convery et 
al., 1998) 
RCT 60 
Patients given 5mg ketorolac with 20ml of 0.25% bupivacaine into 
the joint after surgery provided similar analgesic control to 10mg 
ketorolac given intravenously with 20ml of 0.25% bupivacaine given 
into the joint. 
(Cook et al., 
1997) 
RCT 63 
Patients received either 40ml solution containing only normal saline, 
0.25% bupivacaine or 20mg tenoxicam at the end of knee 
arthroscopy. Less analgesia was needed by the tenoxicam group but 
subjective pain reporting was similar in all groups. 
(Dalsgaard et 
al., 1993) 
RCT 52 
Patients receiving 1mg of morphine intrarticularly at the end of 
surgery had lower pain scores at 8- and 24-hours after surgery and 
used less paracetamol compared to those receiving saline placebo. 
(Drosos et 
al., 2002) 
RCT 30 
No significant difference seen in VAS pain scores between patients 
receiving intra-articular saline, 5mg morphine or 15mg morphine 
following diagnostic arthroscopy or arthroscopic meniscectomy. 
(Elhakim et 
al., 1999) 
RCT 60 
Patients randomised to receive either saline placebo; 2% lidocaine 
and 10mg pethidine, or; 2% lidocaine, 10mg pethidine and 20mg 
tenoxicam. Combination of all three agents resulted in lower VAS 
pain scores for longer and less need for analgesic use. 
(Elsharnouby 
et al., 2008) 
RCT 108 
Patients receiving 1g magnesium sulfate and 0.25% bupivacaine 
(20ml total) had significantly lower VAS pain scores and longer time 
to first analgesic use than thos receiving either agent in isolation or 
placebo. 
(Eren et al., 
2008) 
RCT 90 
Patients receving either 8mg lornoxicam or 50mg bupivacaine had 
less analgesic consumption after surgery than those receiving plcebo. 
Pain rating were lower for those receinving the lornoxicam than thos 
receiving the bupivacaine. 
(Fagan et al., 
2003) 
RCT 40 
Patients receiving pre-emptive injection of bupivacaine with 
adrenaline showed a trend toward needing less analgesia in the 
recovery room than those receiving the injection at completion of 
surgery. 
(Farouk and 
Aly, 2009) 
RCT 80 
A combination of magnesium (150mg) and morphine (2mg) with 20 
ml of 0.25% bupivacaine provided superior analgesic control (lower 
VAS scores and longer time to first analgesic) than either agent alone 
with bupivacaine or bupivacaine alone. 
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Author Setting Number Key findings 
(Franceschi 
et al., 2001) 
RCT 90 
Ropivacaine (75mg in 20ml saline) had quicker onset of effective 
analgesia post-opeatively than morphine (2mg in 20ml saline) with 
lower VAS pain scores in the first 4 hours and equivalent control in 
the first 24 hours. 
(Goodwin et 
al., 2005, 
Goodwin 
and Parker, 
2005) 
RCT 50 
Bupivacaine with epinephrine and morphine or bupivacaine with 
epinephrine alone given either pre- or post-operatively resulted in 
lower pain scores and narcotic onsumption than with epinephrine 
alone. There was a trend toward superior control in those receiving 
the injection pre-operatively. 
(Goodwin 
and Parker, 
2005) 
RCT  
Combinations of bupivacaine, morphine and epinephrine given 
pre- or post-surgery resulted in similar pain control. 
(Grabowska-
Gawel et al., 
2003) 
 56 
Patients received either 10ml 0.5% bupivacaine or 5mg morphine in 
normal saline. Mean time to rescue analgesia was shorter in the 
bupivacaine group but there was no difference in reported VAS pain 
scores. 
(Graham et 
al., 2000) 
RCT 36 
Intra-articular analgesia given at completion of arthroscopy was 
equivalent to pre-operative intravenous regional analgesia with 
respect to post-opertive pain control 
(Gupta et al., 
1999) 
RCT 100 
Knee arthroscopy performed under LA (prilocaine (5mg/ml). 
Morphine (3mg), ketorolac (30mg) or a combination of the two was 
given at completion of surgery.  A combination of morphine and 
ketorolac provided significantly superior analgesia than morphine 
alone or placebo. 
(Hege-
Scheuing et 
al., 1995) 
RCT 59 
Morphine (1mg) given either intra-articularly or intravenously at the 
end of arthroscopy had equivalent analgesic benefit. 
(Izdes et al., 
2003) 
RCT 90 
Patients receiving intra-articular piroxicam (20mg) and 25ml of 
0.25% bupivacaine had longer analgesic duration in cases where 
synovial inflammation was confirmed present than when not 
present.  
(Jacobson et 
al., 2006) 
RCT 120 
Levobupivacaine (5mg/ml) significantly reduced the need for 
analgesia in the first 24 hours post-surgery compared to 
levobupivacaine (2.5mg/ml) and lidocaine (10mg/ml) with 
adrenaline. 
(Jaureguito 
et al., 1995) 
RCT  
Knee arthroscopy [performed under LA. Patients receiving intra-
articular morphine (4mg) had lower VAS pain scores than those 
receiving 0.25% bupivacaine or saline placebo. Less supplemental 
pain medication was needed by the morphine group. 
(Jawish et al., 
1996) 
RCT 33 
Patients receiving a combination of 0.25% bupivacaine with 50g of 
fentanyl had reduced post-operative pain for at least 9 hours post-
surgery when compared to patients receiving 0.25% bupivacaine 
alone or saline placebo. 
(Joshi et al., 
1992) 
RCT 20 
Patients receiving intra-articular morphine (5mg) following knee 
arthroscopy had lower VAS pain scores and needed less rescue 
analgesia than those recevinign saline placebo. Low serum morphine 
metabolites suggested that the morphine was acting locally. 
(Joshi et al., 
1993) 
RCT 40 
Intra-articular morphine (5mg) either in isolation or incombination 
with 25ml of 0.25% bupivacaine resulted in significantly lower pain 
scores and need for supplementary analgesia than bupivacaine in 
isolation or saline placebo. 
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Author Setting Number Key findings 
(Juelsgaard 
et al., 1993) 
RCT 47 
There was no difference in reposrted VAS pain scores or 
acetaminophen use in the 48 hours after knee arthroscopy in patients 
receiving either 2 or 4mg of intra-articular morphine after surgery 
(Kanbak et 
al., 1997) 
RCT  
Patients receiving 5mg morphine intra-articularly after arthroscopy 
had superior pain control in the 24 hours after surgery compared to 
those receiving 1mg morphine or saline placebo. 
(Karaman et 
al., 2009) 
RCT 40 
No significant difference was found in control of post-operative pain 
and analgesic requirement between patients receiving 20ml of 0.5% 
levobupivacaine and 20ml of 0.5% bupivacaine. 
(Kligman et 
al., 2002) 
RCT 60 
Infiltration of morphine (1mg) into the synovial tissue or outer third 
of meniscal tissue resulted in better pain control (lower VAS pain 
scores and less analgesic use) post-arthroscopy than if morphine 
(1mg) was given by the intra-articular route. 
(Lundin et 
al., 1998) 
RCT 50 
Intra-articular bupivacaine 0.25% (40ml) with the addition of 
morphine 1mg compared to bupivacaine alone. Lower VAS pain 
scores noted with the addition of morphine in the 24 hours after 
surgery but no difference in supplementary analgesic use. 
(Niemi et al., 
1994) 
RCT 80 
Patients underwent knee arthroscopy under either spinal or LA  (1% 
lidocaine with adrenaline) blockade. Intra-articular morphine (1mg) 
given at the end of the procedure resulted in  reduced rescue 
analgesia requirement in the group that had LA block. 
(Pooni et al., 
1999) 
RCT 107 
Patients randomized to receive either intra-articular bupivacaine or 
fantanyl after knee arthroscopy reported similar pain scores except 
at 2-hours post-surgery when bupivacaine was superior 
(Raj et al., 
2004) 
RCT 40 
Patients receinving 10mg morphine intra-articularly repoted lower 
pain scores between 4- and 24-hours post-surgery and consumed 
less analgesia than patients receiving 10mg morphine via the 
intramuscular route. 
(Rasmussen 
et al., 2002) 
RCT 60 
Patients randomized to receive either saline placebo; 150mg 
bupivacaine and 4mg morphine, or; 150mg bupivacaine, 4mg 
morphine and 40mg methylprednisolone intra-articulalry at the end 
of surgery.Bupivacaine with mprhine was effective at reducing pain 
and duration of immobilization, the addition of methylprednisolone 
futher reduce dpain and use of analgesics. 
(Rautoma et 
al., 2000) 
RCT 200 
Pre-operative per oral diclofenac reduced post-operative pain scores 
compared to the intra-articular ropivacaine given at the time of 
surgery. Arthoscopy performed under spinal anaesthesia. 
(Richardson 
et al., 1997) 
RCT  
Intra-articular morphine (1mg) was superior to bupivacaine (100mg) 
at reducing pain scores and need for supplementary anlgesia at 6- 
and 24-hours post-surgery. 
An intra-articular dose of 5mg morphine was more effective thatn 
1mg intra-articular or 5mg intravenous at reducing VAS pain scores. 
(Rosseland et 
al., 2004) 
RCT 60 
Intra-articular saline (1 or 10ml) was given following surgery via an 
intra-articular catheter in patients with at least moderate pain. 
Within 1 hour VAS pain scores reduced from 50 to 27 on a 100mm 
scale with both volumes. 
(Rosseland et 
al., 2003) 
RCT 40 
Intra-articular saline (10ml) or morphine (2mg in 10ml saline) was 
given following surgery via an intra-articular catheter in patients 
with at least moderate pain. Equivalent improvements in pain 
intesnity were found in both groups. 
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Author Setting Number Key findings 
(Rosseland et 
al., 1999) 
RCT 90 
Only patients with more intense pain after arthroscopy had beneift 
from intra-articular morphine (2mg) with regard reduced pain 
intensity and analgesia requirement. In most patients morphine (1 or 
2mg) was equivalent to saline placebo. 
(Samoladas 
et al., 2006) 
RCT 60 
Patientes received either 10 or 20ml of 7.5mg/ml ropivacaine. Both 
provided excellent pain control for two hours, however after that the 
lower dose group reported increased pain and need for 
supplementary analgesia. 
(Santanen et 
al., 2001) 
RCT 100 
Knee arthroscopy performed under spinal anaesthesia. 20ml of 0.5% 
ropivacaine failed to reduce VAS pain scores or need for rescue 
analgesia when compared to saline control. 
(Solheim et 
al., 2006) 
RCT 40 
Patients received intra-articular morphine (5mg) or saline placebo 
via intra-articular catheter 1 hour post-surgery if they developed at 
least moderate pain. Morphine was of no greater benefit than saline. 
Timing of catheter removal did not influence the outcome. 
(Souza et al., 
2002) 
RCT 60 
Patients receiving either saline placebo, 10ml 0.25% bupivacaine, 
2mg morphine or 100g fentanyl intra-articularly at the end of 
arthroscopy did not differ significantly in reported pain intensity. 
(Tamosiunas 
et al., 2005) 
RCT 48 
Patients receiving 20ml of 0.5% bupivacaine with the addition of 
1g/kg of clonidine controlled post-operative pain more effectivley 
than bupivacaine in isolation or placebo. 
(Townshend 
et al., 2009) 
RCT 137 
Patients receiving 20ml of 0.5% bupivacaine either intra-articulalry 
or infiltrated around the portals reported equivalent pain scores at 1-
hour post-surgery. 
(VanNess 
and Gittins, 
1994) 
RCT 81 
Patients receiving intra-artticular morphine (2mg) reported 
significantly less pain and lower analgesic requirements in the 24-
hours after surgery than those receiving 30ml of 0.25% bupivacaine 
with epinephrine.. 
(Varrassi et 
al., 1999) 
RCT 48 
Intra-articular buprenorphine (100g) and intra-articular 
bupivacaine (50mg) resulted in lower VAS pain scores in the 6-hours 
after surgery than intra-articular saline or intra-muscular 
buprenorphine. Analgesic use was less in thoe treated with intra-
articular buprenorphine or bupivacaine. 
(Vranken et 
al., 2001) 
RCT 60 
Sufentanil (5 or 10g) given intra-articulalry resulted in lower VAS 
pain scores than in control (intravenous sufentanil). Post-operative 
analgesic use was also lower in the treatment group. 
(White et al., 
1990) 
RCT  
Patients treated with prilocaine with adenaline reported prolonged 
time to first dose of oral analgesia but overall there was no difference 
in pain scores. 
(Yang et al., 
1998) 
RCT 60 
Patients receiving intra-articular neostigmine (500g) had lower 
VAS pain scores 1-hour after surgery and had longer lasting 
duration of analgesia compared to those receiving intra-articular 
morphine (2mg) or saline placebo. No significant effects were seen 
with neostigmine 125 or 250g. 
(Zeidan et 
al., 2008) 
RCT 90 
Intra-articular administration of tramadol (100mg) and 0.25% 
bupivacaine to 20ml vloume had lower VAS scores, longer time to 
rescue analgesia and less analgesic use in the first 24-hours 
compared to when either agent was given in isolation. 
Table 2. Studies assessing the benefit of intra-articular analgesic agents following knee 
arthroscopy. Treatments are in bold. 
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In summary a myriad of agents have been studied for their potential use in attenuating post-
operative pain following knee arthroscopy. While the amide local anesthetic agents are the 
most widely studied their continuing benefit and use is questionable as portal infiltration 
has been shown to be as effective at providing pain control for a procedure that is generally 
very well tolerated. Knee arthroscopy performed under local anesthetic is a different entity 
although far less frequent. 
Hip and ankle arthroscopy are far less studied and the ideal intra-articular agent is 
uncertain in these joints. A multi-model intra-articular analgesic bolus may be the best 
approach in these joints that require significant traction and subsequent injury to the capsule 
that can cause greater discomfort after surgery. 
2.3 The potential for articular chondrocyte toxicity 
The potential for deleterious effects of local anesthetic agents on articular chondrocytes was 
increasingly noted with the use of arthroscopic pain pumps following glenohumeral 
arthroscopy(Busfield and Romero, 2009, Hansen et al., 2007, Solomon et al., 2009). Increasingly 
however studies are alerting the practicing clinician to the potential for toxic effects secondary 
to amide local anesthetics given as a single bolus injection. Most of these are laboratory-based 
studies. Although some have questioned the relevance given the long use of intra-articular 
local anesthetic without seemingly any complication the serve as a caution. 
The aim of this section is to provide an over view of the basic science evidence on the 
potential for local anesthetic agents to cause articular chondrocyte toxicity. 
2.3.1 In vitro reports 
A number of different laboratory modesl utilizing cell lines from a variety of animal species 
have been used in the study of local anaesthetic toxicity. A toxic effect in canine 
chondrocytes exposed to bupivacaine 0.5% using a proven in vitro model by Anz et al. They 
reported an almost 100% reduction in cell viability after two days exposure to bupivacaine. 
Bupivacaine conferred an anti-inflammatory effect in their study, evidenced by reduced 
nitric oxide and PGE rise in the presence of interleukin-1, but their conclusion maintained 
that continuous exposure to bupivacine resulted in a clear toxic effect toward the canine 
chondrocytes(Anz et al., 2009). Again using a canine osteochondral model the toxic effect of 
bupivacaine was again confirmed, with or without the addition of methylparaben(Hennig et 
al., 2010). Exposure to the local anaesthetic alone for 5 or 30 minutes caused significant cell 
death, although this was only significant statistically at the 30 minute exposure.  
Miyazaki et al demonstrated a concentration dependent reduction in bovine chondrocyte 
viability after treatment with lidocaine (0.125, 0.25, 0.5 or 1%) (Miyazaki et al., 2011).  
Glycosaminoglycan (GAG)content of the cells was also noted to be reduced as the 
concentration of the local anaesthetic was increased. GAG and lactate production were 
higher in the cells treated with 0.5 and 1% lidocaine. The authors felt that this finding 
conferred a reparative response by the cells.  
Using bovine articular chondrocytes in alginate bead cultures Karpie et al exposed these to 1 
or 2% lidocaine for 15 to 60 minutes(Karpie and Chu, 2007). A dose and time dependent 
increase in cell toxicity was reported. An intact surface on the osteochondral core or variation 
in the pH of the treatments (pH 7.4, 7.0, 5.0) failed to confer any protective effect (this is in 
contrast to other studies – see below). Others have also reported time and concentration 
dependent reductions in cell viability using a bovine disc model(Lo et al., 2009). In this case 
osteochondral cores were harvested from the radiocarpal joint of cows and these were treated 
with either lidocaine (1%), bupivacaine (0.25%) or ropivacaine (0.5%).  
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The toxic effects of bupivacine (0.125, 0.25 and 0.5%) on the the articular chondrocyte from a 
bovine cell line were well demonstrated (Chu et al., 2008). Cells were cultured in a 3-
dimensional alginate-bead culture. Specimens were exposed for 15, 30 or 60 minutes and 
analysis was performed at 1 and 24 hours and at 1 week. A clear time and concentration 
dependent respose to the local anaetshetic treatments was observed. Treatment with 0.125% 
bupivacaine for 15 minutes was not significantly different to the saline control. Almost 
complete loss of cell viability was noted with 0.5% bupivacaine. Analysis of osteochondral 
cores with an intact superficial cell layer suggested that an the superficial layer of the 
articular cartilage provided some protective benefit when intact. This may be significant in 
deciding during surgery whether or not intra-articular analgesic agents are safe to 
administer. 
To test the respective toxic effects on chondrocytes of lidocaine, mepivacaine and 
bupivacaine Park et al used an equine model (Park et al., 2011). Bupivacaine (0.5%) was the 
most toxic of the agents used with cell viability reduced to 29 +/- 8% after 30 minutes. Cell 
viability after treatment with saline was 96%. Lidocaine and mepivacaine were both less 
toxic with mepivacine exerting the least toxic effect of the three. 
A number of studies have used human cell lines which is arguably more useful for the 
extrapolation of results into clinical pratice. Dragoo et al used a custom made bioreactor to 
mimic the metabolism of synovial fluid to simulate the use of a pain pump following 
arthroscopic surgery(Dragoo et al., 2008). They found that both lignocaine (1%) and 
bupivacaine (0.25 or 0.5%) resulted in reduced cell viability but that the  rates of necrosis 
were noted with the presence of epinephrine.  Cell viability was similar at 24 and 48 hours 
in the bupivaine group, but there was a greater toxic effect seen at 72 hours. Further work 
using the same bioreactor model demonstrated that epineprhine, at levels of 1:100000-
200000, conferred no significant increase in cell death compared to acidic media with a pH 
of 4.5-5.0 and local anaesthetics in combination with epinephrine (Dragoo et al., 2010). The 
authors suggest that local anaesthetic agents containing epinephrine should be used with 
caution as these are often titrated to a low pH. 
Syed et al reported significant toxic effects of bupivacaine either alone or in combination 
with triamcinolone in a monlayer culture model using human articular chondrocytes (Syed 
et al., 2011). When the treatments were administered to the osteochondral plug with an 
intact surface however, the toxic effect of bupivacaine in isolation was no more than that of 
the control – again suggesting there is a benefit to an intact articular surface with regard 
exposure to potentially toxic agents.  
Using chondrocytes harvested from osteoarthritic human knees it was demonstrated that 
exposure to lidocaine, bupivacaine or ropivacaine for 24 or 120 hours resulted in significant 
levels of cell death(Grishko et al., 2010). In the lignocaine 2% group massive necrosis was 
seen at 24 hours. After 120 hours exposure there were significant dereases in cell viability in 
all treatments groups with the exception of those cells treated with 0.2% ropivacaine. As 
viability decreased a concomitant rise in cell apoptosis was noted. 
Jacobs et al harvested human articular chondrocytes from the knees of human tissue donors 
or patients undergoing total knee arthroplasty(Jacobs et al., 2011). They treated the articular 
chondrcytes with either 1% or 2% lidocaine with or without epinephrine and used saline as 
a control. Cell death between 91-99% was seen for each of the three treatments. A prolonged 
exposure time was also associated with higher rates of cell death. 
Ropivacaine 0.5% was found to be significantly less toxic to human chondrocytes than 
bupivacaine 0.5% (Piper and Kim, 2008). Normal human articular cartilage was harvested 
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from the femoral head or tibial plateau in in patients underoing surgical procedures. Full 
thickness explants and cultured chondrocytes were treated with either ropivacaine or 
bupivacaine for 30 minutes. Cell viability in the explant cultures fell to 95% and 78% after 
treatment with ropivacaine and bupivacaine respectively. Viability in the cell cultures fell to 
64% and 37%. The viability of the cells in the explant cultures treated with ropivacaine did 
not differ significantly to that in the controls treated with saline. Ropivacaine may therefore 
confer a much more acceptable risk than bupivacaine – an important consideration if using 
it as an intra-articular agent following arthroscopy. 
However, others failed to find a difference between these two agents using a simple 
monolayer culture model. Both ropivacaine and bupivacaine conferred simlar toxic effects to 
the articular chondrocytes either in isolation or if they were used in combination with 
magnesium sulfate(Baker et al., 2011b, Baker et al., 2011d). Lignocaine combined with 
magnesium sulfate was less toxic than either ropivacaine, bupivacaine or levobupivacaine 
combined with magnesium suflate after an exposure time of only 15 minutes(Baker et al., 
2011b). 
A useful finding for the practicing surgeon in the studies that have assessed human cells in in 
vitro settings is the recurrent finding that ropivacaine is less toxic than bupivacaine(Baker et 
al., 2011b, Baker et al., 2011d, Piper and Kim, 2008). If ropivacaine confers a less toxic effect, 
then as long as it provides equally efficacious analgesic control, then these studies support its 
use. Notably, Piper et al also found ropivacaine to be less toxic in the explant culture with cells 
embedded in an intact matrix, potentially a better representation of the in vivo state. 
2.3.2 In vivo studies  
In vivo models shoulde in theory provide the best simulation of what may happen in 
pratcice. However, consideration needs to be given to the culture model used and also the 
species studied. Arguably the ideal model is unknown to date and no human in vivo studies 
at the time of writing have been able to demonstrate a lasting deleterious effect of local 
anaesthetic on articular chondrocytes.  
The effect of a single intra-articular injection of 0.5% bupivacaine into a stifle joint compared 
to 0.9% saline control was studied(Chu et al., 2010). Six months following injection gross and 
histological appearances showed that the chondral surfaces remained intact. They diod note 
howeevr, that there was a reduction in chondrocyte density of up to 50% in the joint treated 
with local anaesthetic compared to the saline control. 
In an in vivo rabbit study three groups recieved continuous infusions of either saline, 
bupivacaine or bupivacaine with epinephrine over 48 hours(Gomoll et al., 2006).  One week 
after treatment the animals were sacrificed and osteochondral and synovial samples analysed. 
Bupivacaine with or without epinephrine resulted in cell viability reduction by 20 to 32%. 
Histological analysis was worse in both treatment gourps compared to saline control.  
A similar treatment regime did not result in long term changes in articular cartilage(Gomoll 
et al., 2009). When the rabbits were sacrificed three months after the infusion of the saline of 
local anaesthetic there was no significant difference found between treatment and control 
groups. An increase in cartilage metabolism in the treatment groups was noted suggesting 
that the cartilage was undergoing a reparative process. This study provides conflicting 
information to the earlier one noted by Chu et al creating more difficulty in ascertaining the 
true chronic effect of intra-articular local anaesthetic use. 
In another, histological changes in rabbit knee joint articular cartilage have been reported 
(Dogan et al., 2004). Knees were injected with either 0.9% saline, bupivacaine or 
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neostigmine. Histological analysis performed at 1, 2 and 10 days confirmed more toxic 
changes in both treatment groups compared to saline control. 
2.3.3 The mechaisn of local anaesthetic mediated chondroctoxicity 
Despite a number of studies reporting the potential toxic effects the mechanism by which 
these agents exert their effect is uncertain. Mitochondrial dysfunction is thought to be a key 
factor in articular chondrocyte death(Grishko et al., 2010). Grishko et al demonstrated 
mitochondrial DNA damage and a reduction in ATP and mitochondrial protein levels in 
response to treatment with a variety of local anaesthetics at varying concentrations. 
In another study cells exposed to lidocaine or bupivacine in isolation had rates of cell death 
just over 10%(Bogatch et al., 2010). When the local anaesthetics were mixed with the cell 
culture medium this rate rose to over 96% in each instance. Crystal formation was seen 
when the bupivacine was mixed with culture medium. Acididc phosphate buffered saline 
resulted in increased cell death only when the acidity was increased to a pH less than 3.4. 
Based on these results the authors propose an incompatibility between the synovial fluid 
and the local anaesthetic is responsible for the majority of chondrocyte death rather than the 
local anaesthetic agent itself.  
3. Summary 
A number of different agents have been trialed as intra-articular analgesic agents following 
arthroscopy in the lower limb. Many of the reported trials have focussed on the use of 
amide local anaesthetic sgents as these are the most widely used in clinical practice. Depsite 
multiple studies there is no agent that appears clearly superior to the rest. Bupivacaine or 
ropivacaine appear the most likely to offer the greatest analgesic control by this route and a 
small number of studies are supportive of a multi-modal infiltration. Magnesium sulfate for 
one may be an ideal synergist. 
Although Townsend et al have offered evidence that intra-articular local anaesthetc can be 
avoided in knee arthroscopy without compromising analgesic control, the ideal mode of 
analgesic control in hip and ankle arthroscopy is still uncertain. Recent reports of 
chondrolysis in shoulder arthroscopy prompted a number of investigations in the potential 
toxic effect that amide local anaesthetcis may have on articular chondrocytes. 
Ropivacaine appears to less toxic than bupivacaine and a combination of ropivacaine and 
magnesium has also been suggested as a more acceptable alternative approach to intra-
articular local anaesthesia(Baker et al., 2011b, Webb and Ghosh, 2009). The potential 
diffculties in applying laboratory findings to the clinical setting has been noted(Webb and 
Ghosh, 2009). In the arthroscopic setting, a number of variables including the articular 
surface disease state, the dilutional effect of the arthroscopic fluid and absorbance of injected 
agents into surrounding synovium and adjacent soft tissues could all modify the effect the 
local anaesthetic has on the articular chondrocyte. The potential for toxic effects on articular 
chondrocytes by local anaesthetic needs to be further investigated.  
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